Cardiff Oncology Inc (CRDF)

SG&A Expenses

$3.80M

Quarterly · Period ending: · USD

CRDF logo

CRDF SG&A Expenses

Latest reported$3.80M
CRDF Quarterly SG&A Expenses ($0.00 → $3.80M)
High-resolution chart · PNG

CRDF sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cardiff Oncology Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
3,804,000
6,126,000
2,995,000
3,897,000
0
4,014,000
3,011,000
0
3,215,000
3,028,000
2,725,000
2,939,000
4,296,000
3,083,000
3,078,000
3,077,000
3,086,000
3,940,000
3,835,000
2,930,000
2,838,000
2,235,000
3,417,014
1,644,000
1,669,000
1,486,000
-2,726,090
2,880,678
1,528,000
1,475,000
1,685,000
1,665,200
2,150,871
2,504,977
1,874,000
4,079,514
4,674,152
3,604,624
4,688,000
5,651,644
5,597,768
7,061,799
4,099,000
3,746,809
3,918,000
2,600,638
2,710,000
2,007,176
1,900,053
1,928,070
1,610,266
2,205,952
1,479,263
1,706,717
1,003,000
739,042
809,868
826,964
602,513
586,230
584,025
551,044
1,450,000
3,270,000
480,000
440,000
0
0
0
627,634
982,897
575,283
651,695
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.